CINECA IRIS Institutional Research Information System

TALIANI, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.410
AS - Asia 10.235
EU - Europa 8.680
SA - Sud America 1.261
AF - Africa 465
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 3
Totale 39.123
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.777
IT - Italia 3.471
SG - Singapore 3.009
CN - Cina 2.693
HK - Hong Kong 1.403
VN - Vietnam 1.394
SE - Svezia 1.239
BR - Brasile 1.033
DE - Germania 902
BG - Bulgaria 551
CA - Canada 486
GB - Regno Unito 444
TR - Turchia 431
FR - Francia 409
FI - Finlandia 380
AT - Austria 318
RU - Federazione Russa 312
JP - Giappone 278
IN - India 269
UA - Ucraina 208
KR - Corea 189
CI - Costa d'Avorio 104
BD - Bangladesh 99
NG - Nigeria 86
CH - Svizzera 83
IQ - Iraq 78
MX - Messico 73
NL - Olanda 70
AR - Argentina 65
SN - Senegal 64
AU - Australia 63
ZA - Sudafrica 59
PL - Polonia 58
BE - Belgio 56
PK - Pakistan 55
ES - Italia 47
ID - Indonesia 45
SA - Arabia Saudita 42
UZ - Uzbekistan 40
VE - Venezuela 34
CO - Colombia 32
EC - Ecuador 32
EG - Egitto 31
KE - Kenya 28
JO - Giordania 25
MA - Marocco 22
CZ - Repubblica Ceca 20
IE - Irlanda 18
MY - Malesia 18
AZ - Azerbaigian 17
DZ - Algeria 17
PY - Paraguay 17
JM - Giamaica 16
LT - Lituania 16
PE - Perù 15
PH - Filippine 14
TT - Trinidad e Tobago 14
AE - Emirati Arabi Uniti 13
KZ - Kazakistan 13
OM - Oman 13
CL - Cile 12
ET - Etiopia 12
IR - Iran 12
TW - Taiwan 12
IL - Israele 11
BO - Bolivia 10
LB - Libano 10
PT - Portogallo 10
AL - Albania 9
HU - Ungheria 9
CR - Costa Rica 8
GE - Georgia 8
GR - Grecia 8
PA - Panama 8
BJ - Benin 7
DK - Danimarca 7
UY - Uruguay 7
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
BF - Burkina Faso 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
EE - Estonia 5
NP - Nepal 5
PR - Porto Rico 5
RO - Romania 5
TN - Tunisia 5
BN - Brunei Darussalam 4
LY - Libia 4
NI - Nicaragua 4
QA - Qatar 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BY - Bielorussia 3
CG - Congo 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KG - Kirghizistan 3
Totale 39.064
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.762
Ashburn 1.743
Singapore 1.678
Ann Arbor 1.492
Hong Kong 1.359
Houston 1.318
Serra 1.185
San Jose 1.074
Fairfield 1.039
Chandler 1.030
Santa Clara 941
Dallas 855
Milan 641
Sofia 550
Shanghai 527
Beijing 523
New York 427
Seattle 424
Wilmington 397
Ho Chi Minh City 383
Ottawa 377
Los Angeles 331
Cambridge 327
Boardman 292
Hanoi 283
Izmir 282
Vienna 267
Princeton 264
Hefei 251
Jacksonville 250
Council Bluffs 225
Lawrence 220
Lauterbourg 217
Tokyo 203
Frankfurt am Main 192
Nanjing 177
Seoul 177
Medford 175
London 166
Des Moines 153
Dong Ket 147
Helsinki 143
Pisa 131
Rho 129
Istanbul 107
Abidjan 104
Redondo Beach 103
Dearborn 102
Rome 102
Munich 88
Buffalo 84
São Paulo 84
Lagos 83
Bremen 75
Florence 70
Chicago 68
Da Nang 64
Dakar 64
San Diego 61
Nanchang 60
Turku 60
Brussels 55
Bern 54
The Dalles 50
Redwood City 49
Boulder 48
Columbus 48
Ogden 48
Orem 47
Haiphong 46
Kunming 45
Warsaw 45
Düsseldorf 42
Pune 42
Jüchen 41
Sydney 41
Lucca 40
Changsha 38
Fuzhou 38
Shenyang 38
Tashkent 38
Hebei 35
San Francisco 35
Johannesburg 34
Paris 32
Toronto 32
Belo Horizonte 31
Livorno 31
Tianjin 31
Baltimore 30
Dhaka 29
Manchester 28
Rio de Janeiro 28
Guangzhou 27
Nuremberg 27
Nürnberg 27
Baghdad 26
Quanzhou 26
Hangzhou 25
Brasília 24
Totale 27.557
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 407
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 332
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 297
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 292
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 277
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 274
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 271
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 258
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 253
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 252
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 242
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 240
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 236
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 232
Allosteric modulators of human A2B adenosine receptor. 230
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 230
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 227
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 227
Metformin conjugates and therapeutic use thereof 223
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 222
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 220
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 216
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 214
An update into the medicinal chemistry of translocator protein (TSPO) ligands 213
Structure-Based Lead Optimization and Biological Evaluation of BAX Direct Activators as Novel Potential Anticancer Agents. 212
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 212
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 212
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 209
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 209
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 208
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 207
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 205
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 205
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 204
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 203
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 202
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 202
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 200
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 199
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 199
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 198
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 197
TSPO Radioligands for Neuroinflammation: An Overview 196
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 196
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 196
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 195
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 193
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 193
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 193
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 193
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 192
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 192
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 191
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 190
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 190
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 189
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 189
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 188
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 188
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 188
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 187
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 187
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 187
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 187
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 186
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 185
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 185
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 183
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 183
The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 182
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 181
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 179
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 179
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 178
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 178
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 178
Characterization of a new fluorescent irreversible ligand to translocator protein (18 kDa) 176
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 176
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 176
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 175
Antitumoral effect by induction of collapse of mitochondrial membrane potential in Glioblastoma Multiforme cells 173
Carbonic anhydrase activation profile of indole-based derivatives 173
Nuovi derivati acidi acetici quali potenti inibitori dell’Aldoso Reduttasi 171
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 171
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 171
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 170
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABA(A) receptor activity 170
Human oligodendrocyte-like cell differentiation is promoted by TSPO-mediated endogenous steroidogenesis 169
New fluorescent probes for the pheripheral-type benzodiazepine receptor: synthesis and biological application 169
Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise 168
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 168
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 168
A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites 167
Highlighting the new advances in drug discovery and development 167
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 167
De novo neurosteroidogenesis in human microglia: Involvement of the 18 kda translocator protein 167
Synthesis and Biological Evaluation of Pyrido[1,2-d]pyrimidin-4-one Derivatives as Novel Aldose Reductase Inhibitors Exhibiting Antioxidant Activity 166
Allosteric modulation of A2B adenosine receptors potentiate the effects of orthosteric receptor agonists to promote mesenchymal stem cell differentiation to osteoblasts. 166
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 166
Totale 20.249
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 0 0 0 0 0 0 115 337
2021/20222.662 79 229 119 142 421 377 100 116 95 72 147 765
2022/20233.787 449 581 274 373 421 483 39 276 643 22 177 49
2023/20242.829 310 282 306 190 406 505 174 72 39 68 165 312
2024/20258.212 60 286 103 526 853 829 570 370 754 1.061 872 1.928
2025/20269.587 472 1.134 1.085 774 978 791 2.200 478 655 916 104 0
Totale 39.774